Details for New Drug Application (NDA): 020802
✉ Email this page to a colleague
The generic ingredient in EXCEDRIN (MIGRAINE RELIEF) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Summary for 020802
Tradename: | EXCEDRIN (MIGRAINE RELIEF) |
Applicant: | Haleon Us Holdings |
Ingredient: | acetaminophen; aspirin; caffeine |
Patents: | 0 |
Pharmacology for NDA: 020802
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Central Nervous System Stimulation Decreased Platelet Aggregation Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 020802
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802 | NDA | Haleon US Holdings LLC | 0067-2035 | 0067-2035-20 | 1 BOTTLE in 1 CARTON (0067-2035-20) / 20 TABLET, COATED in 1 BOTTLE |
EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802 | NDA | Haleon US Holdings LLC | 0067-2035 | 0067-2035-80 | 1 BOTTLE in 1 CARTON (0067-2035-80) / 80 TABLET, COATED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 250MG;250MG;65MG | ||||
Approval Date: | Jan 14, 1998 | TE: | RLD: | Yes |
Expired US Patents for NDA 020802
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Haleon Us Holdings | EXCEDRIN (MIGRAINE RELIEF) | acetaminophen; aspirin; caffeine | TABLET;ORAL | 020802-001 | Jan 14, 1998 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription